- •Preface
- •Contributors
- •Contents
- •Introduction
- •Literature Review
- •Major Issues
- •Major Studies
- •Negative Studies
- •References
- •1.1.1 Introduction
- •1.1.3 Torsional Ultrasound
- •1.1.4 Our Procedure for Emulsifying the Nucleus
- •References
- •1.2 Transitioning to Bimanual MICS
- •1.2.1 Introduction
- •1.2.2 Technique
- •1.2.3 Summary
- •1.3 0.7 mm Microincision Cataract Surgery
- •1.3.1 Sub 1 mm MICS: Why?
- •1.3.3 Instrumentation
- •1.3.3.2 0.7 mm Irrigating Instruments
- •1.3.4 Surgery
- •1.3.4.1 Incision
- •1.3.4.2 Capsulorhexis
- •1.3.4.3 Hydrodissection
- •1.3.4.4 Prechopping
- •1.3.5 0.7 mm MICS Combined Procedures
- •1.3.5.1 0.7 mm MICS and Glaucoma Surgery
- •1.3.6 Summary
- •References
- •2. MICS Instrumentation
- •2.1 MICS Instrument Choice: The First Step in the Transition
- •2.2 MICS Incision
- •2.3 MICS Capsulorhexis
- •2.4 MICS Prechopping
- •2.5 MICS Irrigation/Aspiration Instruments
- •2.5.1 19 G Instruments
- •2.5.2 21 G Instruments
- •2.6 MICS Auxiliary Instrument
- •2.6.1 Scissors
- •2.6.2 Gas Forced Infusion
- •2.6.3 Surge Prevention
- •2.7 New MICS Instruments
- •2.7.1 Flat Instruments
- •References
- •3.1 Introduction
- •3.2 Power Generation
- •3.3.1 Tuning
- •3.2.2 Phaco Energy
- •3.2.2.1 Low Frequency Energy
- •3.2.2.2 High Frequency Energy
- •3.2.3 Transient Cavitation
- •3.2.4 Sustained Cavitation
- •3.3.1 Alteration of Stroke Length
- •3.3.2 Alteration of Duration
- •3.3.2.1 Burst Mode
- •3.3.2.2 Pulse Mode
- •Micro Pulse (Hyper-Pulse)
- •Pulse Shaping
- •3.3.3 Alteration of Emission
- •3.4 Fluidics
- •3.5 Vacuum Sources
- •3.6 Surge
- •3.7.1 Micro-incisional Phaco
- •3.7.2 Bimanual Micro-Incisional Phaco
- •3.7.3 Micro-Incisional Coaxial Phaco
- •3.7.3.1 Irrigation and Aspiration
- •3.8 Conclusion
- •Reference
- •Further Reading
- •4.1 Introduction
- •4.3 Incision Size
- •4.4 Torsional Ultrasound
- •4.5 Conclusion
- •References
- •5. Technology Available
- •5.1 How to Better Use Fluidics with MICS
- •5.1.1 Physical Considerations
- •5.1.1.2 Chamber Stability
- •5.1.1.3 Holdability
- •5.1.2 Surgical Considerations
- •5.1.2.2 Phaco Technique
- •5.1.2.4 The OS3 and CataRhex SwissTech Platforms
- •Equipment
- •Machine Settings
- •5.2 How to Use Power Modulation in MICS
- •5.2.1 Introduction
- •5.2.3 The Concept of Unoccluded Flow Vacuum
- •5.2.4 The Intricacies of Ultrasound Power Modulation
- •5.2.5 The Variable Incidence of Wound Burn Rates
- •References
- •5.3 MICS with Different Platforms
- •5.3.1 MICS with the Accurus Surgical System
- •5.3.1.1 Introduction and Historic Background
- •5.3.1.3 Surgical Parameters for MICS with Accurus
- •5.3.1.4 Final Considerations
- •5.3.2.1 Introduction
- •5.3.2.7 Technology for MICS on the AMO Signature
- •5.3.2.8 Applying Signature Technology to CMICS and BMICS
- •5.3.3 MICS with Different Platforms: Stellaris Vision Enhancement System
- •5.3.3.2 Evaluating the Stellaris Vision Enhancement System
- •5.3.3.3 The Advantages of BMICS
- •References
- •6.1 Pupil Dilation and Preoperative Preparation
- •6.1.1 Managing the Small Pupil
- •6.1.2 Techniques that Depend on the Manipulation of the Pupil
- •6.1.3 Iris Surgery
- •6.1.4 Preoperative Preparation and Infection Prophylaxis
- •6.1.5 Evaluating Risk
- •6.1.6 Assessing Your Approach
- •6.1.7 Preventing Infection, Step by Step
- •6.1.8 Sample Protocol Outline
- •6.1.9 A Careful, Critical Eye
- •References
- •6.2 Incisions
- •References
- •6.3 Thermodynamics
- •6.3.1 Introduction
- •6.3.2 Corneal Thermal Damage
- •6.3.3 Heat Generation
- •6.3.4 Factors that Contribute to Thermal Incision Damage
- •6.3.4.1 Energy Emission: Amount and Pattern of How the Energy Is Delivered
- •6.3.4.3 Viscoelastic Devices and Possible Occlusion of the Aspiration Line
- •6.3.4.4 Irrigation Flow
- •6.3.4.5 Position of the Tip Inside the Incision
- •6.3.4.6 Tip Design
- •6.3.4.7 Surgical Technique
- •6.3.5 Conclusion
- •6.4 Using Ophthalmic Viscosurgical Devices with Smaller Incisions
- •6.4.1 Introduction
- •6.4.1.1 The Nature of OVDs: Rheology
- •6.4.1.3 Soft Shell and Ultimate Soft Shell Technique (SST & USST)
- •6.4.2 Routine, Special and complicated Cases
- •6.4.2.1 Phakic and Anterior Chamber IOLs
- •6.4.2.3 Fuchs’ Endothelial Dystrophy
- •6.4.2.5 Capsular Staining for White & Black Cataracts
- •6.4.2.6 Flomax® Intraoperative Floppy Iris Syndrome USST
- •6.4.3 Discussion
- •References
- •6.5 Capsulorhexis
- •References
- •References
- •6.7 Biaxial Microincision Cataract Surgery: Techniques and Sample Surgical Parameters
- •6.8.1 Surgical Technique
- •6.8.2 Advantages
- •6.8.3 Disadvantages
- •6.8.4 Final Thoughts
- •References
- •6.9 BiMICS vs. CoMICS: Our Actual Technique (Bimanual Micro Cataract Surgery vs. Coaxial Micro Cataract Surgery)
- •6.9.1 Introduction
- •6.9.2 Historical Background
- •6.9.3 BiMICS. BiManual MicroIncision Cataract Surgery
- •6.9.3.1 Introduction
- •6.9.3.2 Instrumentation
- •6.9.3.5 Phacotips
- •6.9.3.6 Capsulorhexis
- •6.9.3.7 Phaco Knives
- •6.9.3.8 The Phaco Machines
- •6.9.3.9 Phaco Pumps
- •6.9.3.10 Ultrasound Power Delivery
- •6.9.3.11 IOL Implantation
- •6.9.3.12 Astigmatism
- •6.9.4.1 Capsulorhexis
- •6.9.4.2 Phacotips
- •6.9.4.3 The Phaco Machines
- •6.9.4.4 Phaco Pumps
- •6.9.4.5 Ultrasound Power Delivery
- •6.9.4.6 Irrigation-Aspiration
- •6.9.4.7 Incision-Assisted IOL Implantation
- •6.9.5 Conclusion
- •References
- •6.10 Endophthalmitis Prevention
- •6.10.1 Antibiotic Prophylaxis
- •6.10.2 Wound Construction
- •6.10.3 Summary
- •References
- •7.1 High Myopia
- •7.2 Posterior Polar Cataract
- •7.3 Posterior Subluxed Cataracts
- •7.4 Mature Cataract with Zonular Dialysis
- •7.5 Punctured Posterior Capsule
- •7.6 Posterior Capsule Rupture
- •7.7 Pseudoexfoliation
- •7.8 Rock-Hard Nuclei
- •7.9 Switching Hands
- •7.10 Microcornea or Microphthalmos
- •7.11 Large Iridodialysis and Zonular Defects
- •7.12 Intraoperative Floppy Iris Syndrome (IFIS)
- •7.14 Iris Bombé
- •7.15 Very Shallow Anterior Chambers
- •7.16 Refractive Lens Exchange
- •7.18 Intraocular Cautery
- •7.19 Biaxial Microincision Instruments
- •References
- •7.1 MICS in Special Cases: Incomplete Capsulorhexis
- •7.1.1 Introduction
- •7.1.2 Avoiding Complications While Constructing Your Microcapsulorhexis
- •7.1.3 Avoiding Complications During Biaxial Phaco with an Incomplete Capsulorhexis
- •7.1.4 Avoiding Complications During IOL Insertion with an Incomplete Capsulorhexis
- •7.1.5 Conclusions
- •References
- •7.2 MICS in Special Cases (on CD): Vitreous Loss
- •7.2.1 Introduction
- •7.2.2 Posterior Capsule Tears and Vitreous Prolapse
- •7.2.3 Vitreous and the Epinucleus or Cortex
- •7.2.4 Different Techniques Other than Pars Plana Vitrectomy for Nuclear Loss in Vitreous
- •7.2.5 Pars Plana Vitrectomy
- •7.2.6 Zonulolysis
- •References
- •7.3 How to Deal with Very Hard and Intumescent Cataracts
- •7.3.1 Introduction
- •7.3.2 Types of Cataracts
- •7.3.3 Management of Hard Cataracts Through Biaxial Technique
- •7.3.4 Incision
- •7.3.5 Capsulorrhexis
- •7.3.6 Hydrodissection
- •7.3.8 Conclusion
- •References
- •8. IOL Types and Implantation Techniques
- •8.1 MICS Intraocular Lenses
- •8.1.1 Introduction
- •8.1.2 Lenses
- •8.1.2.2 ThinOptX MICS IOLs (ThinOptX, Abingdon, VA)
- •8.1.2.3 Akreos MI60 AO Micro Incision IOL (Bausch & Lomb, Rochester, NY)
- •8.1.2.4 IOLtech MICS lens (IOLtech, La Rochelle, France; and Carl Zeiss Meditec, Stuttgard, Germany)
- •8.1.3 Optical Quality of MICS IOLs
- •8.1.4 Conclusion
- •References
- •8.2 Implantation Techniques
- •8.2.2 Prerequisites to a Sub-2 Injection
- •8.2.3 IOLs Used for Injection Through Microincision
- •8.2.3.1 Material
- •8.2.3.2 Design
- •8.2.3.3 Optic Design
- •8.2.3.4 Haptic Design
- •8.2.3.5 Posterior Barrier (360°)
- •8.2.4 Injectors Meant for Microincision
- •8.2.4.1 Objectives of Injectors Meant for Microincision
- •8.2.4.2 Characteristics of Sub-2 Injectors
- •8.2.4.3 The Cartridges
- •Loading Chambers
- •Injection Tunnels and Cartridge Tips
- •8.2.4.4 The Plunger Tips (or plunger)
- •8.2.4.5 Pushing Systems
- •8.2.4.6 Injector Bodies
- •8.2.4.7 Principal Sub-2 Injectors
- •8.2.5 Visco Elastic Substances and Injection Through Microincision
- •8.2.6 Techniques of Sub-2 Injection
- •8.2.6.2 Incision Construction
- •8.2.6.3 Pressurization of the Anterior Chamber
- •8.2.6.4 Loading the Cartridge
- •8.2.6.5 Loading the Injector
- •8.2.6.6 Insertion of the Plunger Tip
- •8.2.6.7 Injection in the Anterior Chamber
- •8.2.6.8 Positioning the IOL in the Capsular Bag
- •8.2.6.9 Removing the VES
- •8.2.6.10 Thin Roller Injector
- •8.2.6.11 Conclusion
- •Reference
- •8.3 Special Lenses
- •8.3.1 Toric Posterior Chamber Intraocular Lenses in Cataract Surgery and Refractive Lens Exchange
- •8.3.1.1 Introduction
- •8.3.1.3 T-IOL Calculation
- •8.3.1.4 Current T-IOL Models
- •8.3.1.5 Preoperative Marking
- •8.3.1.6 Clinical Indications
- •8.3.1.7 Custom-Made Lenses
- •8.3.1.8 Conclusion for Practice
- •References
- •8.3.2 Special Lenses: MF
- •8.3.2.1 Discussion
- •8.3.2.2 Conclusion
- •8.3.2.3 Outlook
- •References
- •8.3.3 Special Lenses: Aspheric
- •References
- •8.3.4 Intraocular Lenses to Restore and Preserve Vision Following Cataract Surgery
- •8.3.4.1 Introduction
- •8.3.4.2 Why Filter Blue Light?
- •Summary
- •8.3.4.3 Importance of Blue Light to Cataract and Refractive Lens Exchange Patients
- •Summary
- •8.3.4.4 Quality of Vision with Blue Light Filtering IOLs
- •Summary
- •8.3.4.5 Clinical Experience
- •Summary
- •8.3.4.6 Unresolved Issues and Future Considerations
- •References
- •8.3.5 Microincision Intraocular Lenses: Others
- •8.3.5.1 ThinOptX®
- •8.3.5.2 Smart IOL
- •8.3.5.4 AcriTec
- •8.3.5.5 Akreos
- •8.3.5.7 Rayner
- •8.3.5.8 Injectable Polymers
- •8.3.5.9 Final Comments
- •References
- •9. Outcomes
- •9.1 Safety: MICS versus Coaxial Phaco
- •9.1.1 Introduction
- •9.1.2 Visual Outcomes
- •9.1.3 Incision Damage
- •9.1.4 Corneal Incision Burn
- •9.1.5 Corneal Changes
- •9.1.6 Infection
- •9.1.7 Summary
- •References
- •9.2 Control of Corneal Astigmatism and Aberrations
- •9.2.1 Introduction: Impacts of MICS Incision on the Outcomes of Cataract Surgery
- •9.2.2 Objective Evaluation of Corneal Incision
- •9.2.3 Control of Corneal Aberration and Astigmatism with MICS
- •9.2.4 Role of Corneal Aberrometry in Evaluating MICS Incision
- •9.2.5 Role of OCT in Evaluating MICS Incision
- •9.2.6 Our Experience in Corneal Aberrations and Astigmatism After MICS
- •9.2.7 Conclusion
- •References
- •9.3 Corneal Endothelium and Other Safety Issues
- •9.4 Incision Quality in MICS
- •9.4.1 Introduction: History of Incision Size Reduction
- •9.4.2 The Trends Towards Microincision Cataract Surgery (BMICS)
- •9.4.3 Advantages of Minimizing the Incision Size
- •9.4.4 Model for the Analysis of Corneal Incision Quality [21]
- •9.4.5 Our Protocol for Evaluation of Incision Quality in BMICS [21]
- •9.4.6 Results
- •9.4.6.1 Visual, Refractive and Biomicroscopic Outcomes
- •9.4.6.2 Incision Imaging (OCT) Outcomes
- •9.4.8 Conclusion
- •References
- •INDEX
244 |
H. Kaymak and U. Mester |
8.3.2 Special Lenses: MF
Hakan Kaymak and Ulrich Mester
Core Messages
ßThe only multifocal IOL that fits through the 1.5 mm incision size is the *Acri.LISA (*Acri.
Tec, Zeiss, Henningsdorf, Germany).
ßAcri.LISA is an acronym of the main optical properties of the lens.
ßVisual acuity for distance vision is very good with Acri.LISA and is comparable with that of
monofocal IOLs, at least under photopic lighting conditions.
ßNear vision is also sufficient despite the unequal light distribution of the *Acri.LISA in
favor of the far distance.
ßPatients with the Acri.LISA have a pseudoaccommodation range of 5.5 diopters.
ßInitial results of the toric version of the Acri. LISA are very promising.
Table 8.4 Characteristics of Acri.LISA
Optic diameter |
6.0 mm |
|
Total diameter |
11.0 mm |
Acri.LISA |
Haptic angulation |
0° |
|
Design |
Square edged optic and |
|
|
haptic |
|
|
Single-piece, +3.75 D |
|
|
addition, SMP- |
|
|
technology, refractive |
|
|
/ defractive 65:35 |
|
|
aberration-correcting, |
|
|
MICS |
|
Lens design |
|
|
Incision size |
1.5 – 1.7 mm |
|
Material |
Foldable acrylate with |
|
|
25% water content, |
|
|
hydrophobic surface, |
|
|
UV absorber |
|
Sterilization method |
Autoclaving |
|
Diopter range |
±0.0 to +32.0 D, 0.5 D |
|
|
increment |
|
Package |
Sterile, in water for |
|
|
injection |
|
Recommend |
Acoustic/optic |
|
A-factor: |
|
|
AL < 25.00 mm |
117.6/117.9 |
|
AL ≥ 25.00 mm |
118.0/118.3 |
|
|
A2-2000 |
|
Injector system |
Acri.Smart cartridge |
|
The use of multifocal intraocular lenses (MIOL) has been very limited in the past due to several drawbacks and limitations [1]: Surgical techniques were not as refined and predictable as today and accurate biometry to achieve emmetropia was challenging. Moreover, independence from glasses could not be achieved in all patients, particularly for near vision. Many patients complained of photic phenomena [2, 3], and driving was impaired due to reduced contrast sensitivity under mesopic conditions [4, 5].
Meanwhile, a new generation of MIOLs has been developed and investigated in clinical studies. Several new optical concepts were incorporated in these lenses:
The only multifocal IOL that fits through the 1.5 mm incision size is the *Acri.LISA (*Acri.Tec, Zeiss,
H. Kaymak ( )
Department of Ophthalmology, Knappschafts Hospital, Sulzbach, Germany
e-mail: sek-augen@kksulzbach.de
Henningsdorf, Germany). The characteristics of this MIOL are summarized in Table 8.4. Acri.LISA is the acronym of the main optical properties of the lens (Fig. 8.38).
With the application of a diffractive optic, the visual performance became independent of the pupil size, which was a major drawback of the previous MIOL-generation with refractive optics.
The introduction of an aspheric lens design enhanced contrast vision, which could be demonstrated previously in clinical studies with monofocal IOLs [6–8].
Another new concept is that of unequal light distribution for distance and near vision, based on the consideration that most patients prioritize distance vision. This concept may also lead to a reduction of halos.
To reduce the complaints due to straylight, smooth steps within the diffractive pattern were engineered (Fig. 8.38).
Clinical studies were performed with this MIOL. Thirty patients with bilateral implantation of the
*Acri.LISA were examined 1 year after surgery of the second eye.
8.3.2 Special Lenses: MF |
245 |
Fig. 8.38 Acri.Lisa |
Light distribution 65% far 35% near |
|
(in both eyes!!) |
|
Independent of pupil size |
|
Smooth steps in diffractive structure |
|
Aberration correcting |
LISA
main zone
phase zones between
the main zones
main zone
(acc. to Fiala)
front profile of a bifocal LISA lens (‘smooth steps’)
|
|
|
|
|
|
|
Distance visual acuity |
||||||||||
|
1.60 |
|
|
|
|
|
Influence of binocularity |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(decimal) |
1.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.80 |
|
|
|
|
|
|
|
|
|
|
|
|
binocular |
|||
|
|
|
|
|
|
binocular |
|
|
|
|
|
|
|
||||
VA |
0.60 |
|
|
|
|
|
monocular |
||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
monocular |
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
0.40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
uncorrected |
best corrected |
|||||||||||||
|
0.00 |
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Fig. 8.39 Mean values and standard deviation of distance visual acuity
Monocular and binocular visual acuity (VA) (uncorrected and best corrected) at the 1 year control period are shown in Fig. 8.39. Despite the dominance for far distance of this MIOL, near VA is also very satisfying (uncorrected monocular 0.85, binocular 1.05 under photopic conditions) (Fig. 8.40).
The near uncorrected VA was tested under two lighting conditions demonstrating a luminance depending improvement from 0.8 (80 lux) to 1.0 (350 lux) (Fig. 8.41).
The defocus curve demonstrated the drop of VA at intermediate distance, but not exceeding the critical limit of 0.5 (Fig. 8.42).
The contrast sensitivity was within the normal range under photopic conditions (Fig. 8.43).
With regard to photopic phenomena after 1 year, almost no patient described halos in everyday life.
Overall patients’ satisfaction was 8.3 using a scale from 0 to 10 after 1 year (Fig. 8.44).
8.3.2.1 Discussion
The Acri.LISA offered good efficacy, predictability and satisfying functional outcomes. Our results are in accordance with the findings of Alió et al. [1] and Alfonso et al. [2]. Alió et al. [1] demonstrated very good MTF values of the Acri.LISA for 3 and 6 mm pupil sizes which reflected our clinical outcomes.
8.3.2.2 Conclusion
VA for distance vision is very good with Acri.LISA and comparable with monofocal IOLs, at least under photopic lighting conditions.
246 |
H. Kaymak and U. Mester |
Fig. 8.40 Mean values and standard deviation of near visual acuity
Near Visual Acuity Influence of binocularity
|
1.40 |
|
|
|
|
|
1.20 |
|
|
|
|
(decimal) |
1.00 |
|
|
|
|
0.60 |
|
|
|
|
|
|
0.80 |
|
|
|
|
VA |
0.40 |
|
|
|
|
|
0.20 |
monocular |
binocular |
monocular |
binocular |
|
|
uncorrected |
bestcorrected |
|
|
|
|
|
|
Near binocular Visual Acuity (C.A.T.) Influence of luminance
|
1.40 |
(decimal) |
1.20 |
0.60 |
|
|
1.00 |
|
0.80 |
VA |
0.40 |
Fig. 8.41 Mean values and |
0.20 |
|
|
standard deviation of near |
0.00 |
visual acuity under different |
|
lighting conditions |
|
Defocus Curve
uncorrected
80 lux
3.0
letters) |
(binocular with distance correction) |
|
|
|
|
|
|||||
|
|
|
|
|
|
||||||
|
400 200 100 |
67 |
40 |
50 |
33 |
29 |
25 |
20 |
|
|
2.5 |
|
60.00 |
|
Simulated distance (cm) |
1.25 |
|
|
|||||
(readingCharts |
|
|
|
|
|
|
|
(decimal)VA |
|
||
50.00 |
|
|
|
|
|
|
|
0.80 |
2.0 |
||
|
|
|
|
|
|
|
|
|
|||
|
40.00 |
|
|
|
|
|
|
|
0.50 |
|
1.5 |
|
30.00 |
|
|
|
|
|
|
|
0.32 |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
20.00 |
|
|
|
|
|
|
|
0.20 |
|
1.0 |
ETDRS- |
|
|
|
|
|
|
|
|
|
|
|
Defocus (diopters)
distance corrected
350 lux |
80 lux |
350 lux |
Luminance level
photopic
1,5 |
3 |
6 |
12 |
18 |
Fig. 8.42 Defocus curve with Acri.LISA
Near vision is also sufficient despite the unequal light distribution of the *Acri.LISA in favor of the far distance. A better near VA could be achieved with increasing light luminance. Contrast vision is within the normal range.
There is a significant drop of VA at the intermediate distance. This is because of the bifocal optic of the MIOLs. Therefore, it is advisable to speak of bifocal IOLs instead of multifocal lenses to avoid disappointing patients, who might expect to receive IOLs such as progressive glasses. On the other hand, the drop of VA in
Fig. 8.43 Photopic contrast sensitivity with Acri.LISA (red), normal range (green)
the intermediate distance did not exceed 0.5, which was sufficient for daily activities for most of the patients.
With the Acri.LISA, more than 80% of the patients gained complete independence from spectacles. This is an enormous improvement compared to just one third of patients getting freedom from glasses with the first generation of MIOLs [13].
Even with these newly developed MIOLs, photic phenomena, particularly halos, have not been totally
8.3.2 Special Lenses: MF |
247 |
Overall Satisfaction Score with Acri.Lisa
10.00
|
Better |
8.00 |
|
|
|
|
|
score |
|
|
6.00 |
|
|
||
|
|
4.00 |
|
|
|
|
|
|
Worse |
||
|
2.00 |
||
|
|
|
|
0.00
Fig. 8.44 Satisfaction score after 1 year with Acri.LISA
eliminated. These effects seem to be inherent in MIOLs as a result of multiple images, of which only one is in focus. In fact, most patients are usually not disturbed by these optical effects and report that they become less noticeable over time [14, 15].
All the results in our studies were achieved without additional refinement of refraction using photoablative procedures. Using these techniques, further improvement is likely.
One crucial point is exact biometry. We therefore use three different formulas to get as close to emmetropia as possible. Residual refractive errors enhance the side effects of bifocal lenses and should therefore be avoided.
8.3.2.3 Outlook
Until some time, we did not recommend MIOLs for patients with more than 1 diopter of astigmatism and did not accept a second procedure for refinement. Now
Table 8.5 Characteristics of Acri.LISA toric
Optic diameter |
6.0 mm |
|
Total diameter |
11.0 mm |
Acri. |
|
|
LISA |
|
|
Toric |
|
|
466TD |
Haptic angulation |
0° |
|
Lens design |
Anterior surface toric, |
|
|
posterior surface bifocal, |
|
|
aberration-free, +3.75 D |
|
|
addition, MICS, SMP- |
|
|
technology |
|
Incision size |
1.5 – 1.7 mm |
|
Material |
Foldable acrylate with 25% |
|
|
water content, hydropho- |
|
|
bic surface, UV-absorber |
|
Sterilization |
Autoclaving |
|
method |
|
|
Diopter range |
Spherical: −10.0 D to +32.0 D |
|
|
Cylinder: +1.0 D to +12.0 D |
|
|
Higher diopter on request |
|
Package |
Sterile, in water for injection |
|
Recommend |
Acoustic/optic |
|
A-factor |
|
|
AL < 25.00 mm |
117.6/117.9 |
|
AL ≥ 25.00 mm |
118.0/118.3 |
|
|
Acri.Shooter A2-2000 |
|
Implantation |
Acri.Smart cartridge |
|
system |
|
|
|
Acri.Smart tip |
|
the toric version of Acri.LISA is available (Table 8.5). First results of this MIOL, which were presented at the ASCRS 2008 in Chicago (Table 8.6), are very promising. A multicenter study comparing the Acri.LISA toric with the Acri.LISA combined with a second refractive procedure, in patients with astigmatism of more than 1.5 D, is under way. The results of the first 6 months are expected in 2009.
Table 8.6 First results with the Acri.LISA toric (with permission of Dr. Breyer, Dusseldorf, Germany) |
|
|||||
Patient |
Eye |
Preop refraction |
Target refraction |
Postop refraction objective |
UCVA near + far |
Subjective |
1 |
RA |
−8.50 −2.75 |
+0.21 −0.42 |
+0.50 |
1.0 / 0.9 |
+0.75 |
|
LA |
−5.00 −2.50 |
−0.01 −0.39 |
−0.25 −0.25 |
1.0 / 0.9 |
+0.50 −0.50 |
2 |
RA |
+8.75 −1.00 |
+0.50 −0.42 |
+0.50 |
0.63 / 0.6 |
|
|
LA |
+8.75 −0.50 |
−0.16 −0.60 |
+0.75 −0.50 |
0.63 / 0.6 |
|
3 |
RA |
−4.25 −3.00 |
+0.21 −0.47 |
−0.50 −0.50 |
0.6 / 0.8 |
|
|
LA |
+0.75 −3.25 |
−0.07 −0.46 |
−0.75 −0.25 |
0.6 / 0.8 |
|
4 |
RA |
−7.75 −2.00 |
+0.05 −0.38 |
−0.50 −0.50 |
0.8 / 1.0 |
|
|
LA |
−9.25 −3.75 |
−0.23 −0.48 |
−0.50 −0.75 |
0.8 / 1.0 |
|
5 |
RA |
+5.75 −2.00 |
+0.14 −0.28 |
−0.00 −0.00 |
1.0 / 0.6 |
+0.50 |
|
LA |
+5.50 −2.25 |
−0.04 −0.17 |
−0.00 −0.75 |
0.8 / 0.6 |
+0.25 |
